Zentek于2026年2月17日更新了其药物开发流程进展及与FDA监管合作的情况，但尚未获得新批准。 Zentek updated on Feb. 17, 2026, about progress in its drug development pipeline and regulatory engagement with the FDA, without new approvals.

Zentek有限公司于2026年2月17日宣布了战略和监管最新情况,概述了通过临床发展和监管途径推进其输油管候选人的进展。 Zentek Ltd. announced a strategic and regulatory update on February 17, 2026, outlining progress in advancing its pipeline candidates through clinical development and regulatory pathways. 该公司强调与包括FDA在内的卫生当局的持续互动,并强调制造和试验招生方面的里程碑. The company highlighted ongoing interactions with health authorities, including the FDA, and emphasized milestones in manufacturing and trial enrollment. 没有关于批准新药物的报告,但Zentek确认继续承诺提供创新疗法。 No new drug approvals were reported, but Zentek confirmed continued commitment to delivering innovative therapies.